Web-Based Psychoeducation for Dementia Caregivers
A Web-Based Psychoeducation and Symptom-Monitoring Program to Enhance Dementia Caregiver Self-Efficacy in Managing BPSD
Behavioral and psychological symptoms of dementia (BPSD), such as agitation, anxiety, depression, sleep disturbance, and apathy, are common among people with dementia and often increase the burden on family caregivers. Many caregivers have limited knowledge and confidence in managing these symptoms.
This study aims to evaluate the effectiveness of a 6-week web-based psychoeducation and BPSD symptom-monitoring program in improving caregivers' self-efficacy in managing BPSD. Community-dwelling family caregivers of people with dementia will be recruited from the neurology outpatient clinic of Lotung Poh-Ai Hospital in Taiwan.
Participants will be assigned sequentially to either an intervention group receiving web-based psychoeducation, BPSD symptom monitoring, and usual care, or a control group receiving usual care alone. The primary outcome is caregiver self-efficacy. Secondary outcomes include BPSD severity and caregiver burden.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Behavioral and psychological symptoms of dementia (BPSD) affect most people living with dementia during the course of the disease and are associated with increased caregiver burden, psychological distress, and reduced quality of life. Family caregivers frequently experience difficulties in recognizing BPSD, identifying possible triggers, and applying appropriate management strategies. Although web-based psychoeducation has shown potential benefits for dementia caregivers, evidence regarding its effectiveness in improving caregiver self-efficacy through the integration of structured symptom monitoring remains limited.
This study will evaluate a six-week web-based psychoeducation and BPSD symptom-monitoring program developed for family caregivers of community-dwelling people with dementia. The intervention is delivered through an AppSheet-based online platform and includes six educational modules, BPSD symptom diary recording based on the Neuropsychiatric Inventory Questionnaire (NPI-Q), weekly reminders, and online support when needed. Educational topics include understanding dementia and BPSD, symptom recognition, communication strategies, daily care, caregiver self-care, and community support resources.
This study uses a quasi-experimental two-group pretest-posttest parallel design. Approximately 80 family caregivers will be recruited from the neurology outpatient clinic of Lotung Poh-Ai Hospital, Taiwan. Participants will be assigned sequentially in alternating order to either the intervention group or the usual care control group.
Outcome assessments will be conducted at baseline (Week 0) and immediately after the six-week intervention (Week 6) for both groups. Participants in the intervention group will additionally complete a follow-up assessment at Week 10 to evaluate maintenance of intervention effects.
The primary outcome is caregiver self-efficacy measured using the Revised Scale for Caregiving Self-Efficacy (RSCSE). Secondary outcomes include BPSD severity measured using the Neuropsychiatric Inventory Questionnaire (NPI-Q) and caregiver burden measured using the Zarit Burden Interview (ZBI-22).
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Shan-Hua Chen
- Número de teléfono: 5430 +88639543131
- Correo electrónico: c887034@mail.pohai.org.tw
Ubicaciones de estudio
-
-
Yilan County
-
Luodong, Yilan County, Taiwán, 265
- Reclutamiento
- Lotung Poh-Ai Hospital
-
Contacto:
- Shan-Hua Chen
- Número de teléfono: 5430 +88639543131
- Correo electrónico: c887034@mail.pohai.org.tw
-
Investigador principal:
- Shan-Hua Chen
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Descripción
Inclusion Criteria:
- Family caregivers aged 20 to 90 years.
- The primary caregiver of a community-dwelling person diagnosed with dementia.
- Able to read and understand Chinese.
- Able to use a smartphone, tablet, or computer with Internet access.
- Willing to provide written informed consent and comply with study procedures.
Exclusion Criteria:
- Caregivers of persons with dementia who reside in a long-term care institution.
- Unable to complete study procedures because of cognitive, physical, or communication impairment.
- Currently participating in another intervention study that may influence the study outcomes.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Cuidados de apoyo
- Asignación: No aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Intervention Group
Participants receive a 6-week web-based psychoeducation and symptom-monitoring program in addition to usual care.
The intervention includes six web-based educational modules, BPSD symptom monitoring, weekly reminders, and online consultation when needed.
|
Participants assigned to the intervention group receive a 6-week web-based psychoeducation and symptom-monitoring program in addition to usual care.
The program includes six web-based educational modules on dementia care, BPSD symptom monitoring, weekly reminders to support engagement, and online consultation with the research team when needed.
The intervention is designed to improve caregiver self-efficacy in managing behavioral and psychological symptoms of dementia.
|
|
Sin intervención: Control Group
Participants receive usual care without access to the web-based psychoeducation and symptom-monitoring program during the study period.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Caregiver Self-Efficacy in Managing Behavioral and Psychological Symptoms of Dementia
Periodo de tiempo: Baseline and Week 6
|
Caregiver self-efficacy will be assessed using the Revised Scale for Caregiving Self-Efficacy (RSCSE).
The primary outcome is the change in caregiver self-efficacy from baseline to Week 6 between the intervention and control groups.
|
Baseline and Week 6
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Behavioral and Psychological Symptoms of Dementia
Periodo de tiempo: Baseline and Week 6
|
Behavioral and psychological symptoms of dementia will be assessed using the Neuropsychiatric Inventory Questionnaire (NPI-Q).
The secondary outcome is the change in symptom severity and caregiver distress from baseline to Week 6 between the intervention and control groups.
|
Baseline and Week 6
|
|
Caregiver Burden
Periodo de tiempo: Baseline and Week 6
|
Caregiver burden will be assessed using the 22-item Zarit Burden Interview (ZBI-22).
The secondary outcome is the change in caregiver burden from baseline to Week 6 between the intervention and control groups.
|
Baseline and Week 6
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Shan-Hua Chen, Lotung Poh-Ai Hospital
Publicaciones y enlaces útiles
Publicaciones Generales
- Kales HC, Gitlin LN, Lyketsos CG. Assessment and management of behavioral and psychological symptoms of dementia. BMJ. 2015 Mar 2;350:h369. doi: 10.1136/bmj.h369.
- Steffen AM, McKibbin C, Zeiss AM, Gallagher-Thompson D, Bandura A. The revised scale for caregiving self-efficacy: reliability and validity studies. J Gerontol B Psychol Sci Soc Sci. 2002 Jan;57(1):P74-86. doi: 10.1093/geronb/57.1.p74.
- Yu Y, Xiao L, Ullah S, Meyer C, Wang J, Pot AM, He JJ. The effectiveness of internet-based psychoeducation programs for caregivers of people living with dementia: a systematic review and meta-analysis. Aging Ment Health. 2023 Sep-Oct;27(10):1895-1911. doi: 10.1080/13607863.2023.2190082. Epub 2023 Mar 23.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- LOPAH-BPSD-2026-01
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .